Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NIRAV N SHAH

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1245491257
CMS profile
1224434
Location
MILWAUKEE, WI

General Payments · PY2018–2024

$155,304.49

  • Reported across 182 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$30,798.33

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,768.26 14
PY2019 $36,875.01 42
PY2020 $14,798.55 9
PY2021 $17,902.50 10
PY2022 $23,609.56 19
PY2023 $28,552.28 53
PY2024 $30,798.33 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $800.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1106065728 CMS
ABBVIE INC. $800.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1106065730 CMS
ABBVIE INC. $59.85 09/05/2024 Food and Beverage Undisputed 01/23/2026 1106065732 CMS
ABBVIE INC. $48.38 09/06/2024 Food and Beverage Undisputed 01/23/2026 1106065734 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1105634952 CMS
Celgene Corporation $1,800.00 01/02/2024 Consulting Fee Undisputed 01/23/2026 1101087795 CMS
E.R. Squibb & Sons, L.L.C. $1,800.00 01/02/2024 Consulting Fee Undisputed 01/23/2026 1101240800 CMS
E.R. Squibb & Sons, L.L.C. $6.44 06/25/2024 Food and Beverage Undisputed 01/23/2026 1101240826 CMS
Eli Lilly and Company $132.26 06/01/2024 Food and Beverage Undisputed 01/23/2026 1135259762 CMS
Eli Lilly and Company $32.00 08/16/2024 Food and Beverage Undisputed 01/23/2026 1135291153 CMS
Genentech USA, Inc. $39.14 09/06/2024 Food and Beverage Undisputed 01/23/2026 1133082471 CMS
Genentech USA, Inc. $45.48 12/06/2024 Food and Beverage Undisputed 01/23/2026 1133082475 CMS
Genmab U.S., Inc. $59.26 02/20/2024 Food and Beverage Undisputed 01/23/2026 1126830426 CMS
Genmab U.S., Inc. $69.51 02/23/2024 Food and Beverage Undisputed 01/23/2026 1126830428 CMS
Genmab U.S., Inc. $49.97 06/02/2024 Food and Beverage Undisputed 01/23/2026 1126830424 CMS
Genmab U.S., Inc. $29.90 09/04/2024 Food and Beverage Undisputed 01/23/2026 1126830430 CMS
Incyte Corporation $23.12 09/30/2024 Food and Beverage Undisputed 01/23/2026 1141215516 CMS
Intercept Pharmaceuticals, Inc. $24.35 04/09/2024 Food and Beverage Undisputed 01/23/2026 1113640277 CMS
Iovance Biotherapeutics, Inc. $41.87 04/03/2024 Food and Beverage Undisputed 01/23/2026 1147114592 CMS
Ipsen Biopharmaceuticals, Inc $3,480.00 10/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091992979 CMS
Kite Pharma, Inc. $143.94 12/09/2024 Food and Beverage Undisputed 01/23/2026 1128610205 CMS
Lilly USA, LLC $170.79 03/12/2024 Travel and Lodging Undisputed 01/23/2026 1135241948 CMS
Lilly USA, LLC $8,709.40 03/12/2024 Travel and Lodging Undisputed 01/23/2026 1135259758 CMS
Lilly USA, LLC $7,200.00 03/15/2024 Consulting Fee Undisputed 01/23/2026 1135241952 CMS
Lilly USA, LLC $1,200.00 03/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135289741 CMS
Lilly USA, LLC $84.00 04/01/2024 Travel and Lodging Undisputed 01/23/2026 1135252916 CMS
Lilly USA, LLC $84.00 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1135178579 CMS
Lilly USA, LLC $19.16 04/05/2024 Food and Beverage Undisputed 01/23/2026 1135259767 CMS
Lilly USA, LLC $438.64 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1135291157 CMS
Lilly USA, LLC $9.06 04/05/2024 Food and Beverage Undisputed 01/23/2026 1135304139 CMS
Lilly USA, LLC $109.88 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1135304143 CMS
National Marrow Donor Program $214.51 04/28/2024 Food and Beverage Undisputed 01/23/2026 1111767259 CMS
National Marrow Donor Program $214.56 08/07/2024 Food and Beverage Undisputed 01/23/2026 1111767261 CMS
National Marrow Donor Program $771.93 10/17/2024 Food and Beverage Undisputed 01/23/2026 1111767263 CMS
Novartis Pharmaceuticals Corporation $31.93 12/08/2024 Food and Beverage Undisputed 01/23/2026 1087288991 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.